CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $21,971,000 | +52.8% | 886,659 | +54.6% | 1.83% | +67.6% |
Q1 2022 | $14,382,000 | -46.0% | 573,684 | -21.5% | 1.09% | -29.8% |
Q4 2021 | $26,624,000 | +200.7% | 731,222 | +41.2% | 1.56% | +196.8% |
Q3 2021 | $8,853,000 | +42.0% | 517,708 | +11.2% | 0.52% | +46.0% |
Q2 2021 | $6,235,000 | -32.4% | 465,637 | +158.7% | 0.36% | -35.2% |
Q1 2021 | $9,223,000 | +31.6% | 179,999 | +59.0% | 0.55% | +32.9% |
Q4 2020 | $7,010,000 | +57.5% | 113,213 | +39.4% | 0.42% | +26.4% |
Q3 2020 | $4,451,000 | -20.2% | 81,235 | -16.2% | 0.33% | -6.2% |
Q2 2020 | $5,577,000 | +108.1% | 96,916 | +45.3% | 0.35% | +41.9% |
Q1 2020 | $2,680,000 | -82.0% | 66,695 | -82.3% | 0.25% | -76.9% |
Q4 2019 | $14,907,000 | +1558.2% | 376,944 | +452.2% | 1.07% | +1784.2% |
Q2 2018 | $899,000 | – | 68,258 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |